US3899581A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Triamcinolone acetonide derivative
Assignee: Noucor Health SA
•
Filing: 1974-10-01
•
Granted: 1975-08-12
•
Expires: 1994-10-01
Abstract
Abstract Triamcinolone acetonide 4,4''-methylene-bis(3-methoxy-2naphthoate), method of preparing the same by preparing a reactive derivative of 4,4''-methylene-bis(3-methoxy-2-naphthoic) acid and reacting such derivative with triamcinoline acetonide. The triamcinolone acetonide derivative is particularly suitable for use in the treatment of dermatosis, eczema, neurodermatitis, impetigo, psoriasis, pruritis, erythema and the like.
Inventors
- 👤 Agustin Agusti
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 04:15
CPC Classifications
C; C07; C07J; C07J71/00; C07J71/0005; C07J71/0026; C07J71/0031
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
15 words
A PHARMACEUTICALLY PREPARATION COMPRISING AS ACTIVE INGREDIENT TRIAMCINOLONE ACETONIDE 4,4''-METHYLENE-BIS(3-METHYOXY2-NAPHTHOATE), AND A PHARMACEUTICALLY ACCEPABLE CARRIER.
Claim 2
Dependent Claim
15 words
A PHARMACEUTICALLY PREPARATION COMPRISING AS ACTIVE INGREDIENT TRIAMCINOLONE ACETONIDE 4,4''-METHYLENE-BIS(3-METHYOXY2-NAPHTHOATE), AND A PHARMACEUTICALLY ACCEPABLE CARRIER.
Claim 3
Dependent Claim
13 words
A pharmaceutical preparation according to claim 1 in the form of a cream.
Claim 4
Dependent Claim
21 words
A pharmaceutical preparation according to claim 2 wherein said active ingredient is present in an amount of 0.1 to 0.5 percent.
Claim 5
Dependent Claim
29 words
A method of treating allergic and inflammatory dermatoses which comprises applying to affected areas of the skin a therapeutically effective amount of a pharmaceutical preparation according to claim 1.
Claim 6
Dependent Claim
23 words
A method according to claim 4 which comprises applying said pharmaceutical preparation as 0.1 to 0.5 percent cream 2 or 3 times daily.
Claim 7
Dependent Claim
30 words
A method of treating arthritis, bursitis, tendinitis aNd synovitis which comprises administering to the patient having such condition a therapeutically effective amount of a pharmaceutical preparation according to claim 1.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1978-08-11 | 1979-02-10 | 1979-08-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1982-08-11 | 1983-02-10 | 1983-08-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1986-08-11 | 1987-02-10 | 1987-08-12 | $7700.00 | Window Closed / Lapsed |